<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Knoevenagel condensation &#8211; Science</title>
	<atom:link href="https://scienmag.com/tag/knoevenagel-condensation/feed/" rel="self" type="application/rss+xml" />
	<link>https://scienmag.com</link>
	<description></description>
	<lastBuildDate>Sat, 10 Oct 2026 14:49:23 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://scienmag.com/wp-content/uploads/2024/07/cropped-scienmag_ico-32x32.jpg</url>
	<title>Knoevenagel condensation &#8211; Science</title>
	<link>https://scienmag.com</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">73899611</site>	<item>
		<title>Fluorinated Alcohol Solvent Drives Catalyst-Free Pyran Synthesis in Minutes</title>
		<link>https://scienmag.com/fluorinated-alcohol-solvent-drives-catalyst-free-pyran-synthesis-in-minutes/</link>
		
		<dc:creator><![CDATA[Bethany Barker]]></dc:creator>
		<pubDate>Sat, 10 Oct 2026 14:49:23 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[applications of fused pyrans in pharmacology]]></category>
		<category><![CDATA[biological activities of pyran derivatives]]></category>
		<category><![CDATA[catalyst-free synthesis]]></category>
		<category><![CDATA[environmentally friendly drug precursor synthesis]]></category>
		<category><![CDATA[fluorinated alcohol solvent in catalyst-free pyran synthesis]]></category>
		<category><![CDATA[fluorinated solvents]]></category>
		<category><![CDATA[green chemistry]]></category>
		<category><![CDATA[green chemistry in heterocyclic synthesis]]></category>
		<category><![CDATA[heterocyclic chemistry]]></category>
		<category><![CDATA[HFIP]]></category>
		<category><![CDATA[HFIP as reaction medium and promoter]]></category>
		<category><![CDATA[high-yield organic synthesis]]></category>
		<category><![CDATA[hydrogen bonding]]></category>
		<category><![CDATA[innovative use of fluorinated alcohols in organic chemistry]]></category>
		<category><![CDATA[Knoevenagel condensation]]></category>
		<category><![CDATA[metal-free organic reactions]]></category>
		<category><![CDATA[Michael addition]]></category>
		<category><![CDATA[multicomponent reaction]]></category>
		<category><![CDATA[one-pot multi-component reaction]]></category>
		<category><![CDATA[organic synthesis]]></category>
		<category><![CDATA[pyran synthesis]]></category>
		<category><![CDATA[rapid formation of tetrahydrobenzo[b]pyrans]]></category>
		<category><![CDATA[sustainable methods for heterocycle construction]]></category>
		<category><![CDATA[tetrahydrobenzo[b]pyrans]]></category>
		<guid isPermaLink="false">https://scienmag.com/?p=258990</guid>

					<description><![CDATA[Chemists report that the fluorinated solvent HFIP alone can promote a one-pot, catalyst-free synthesis of biologically important pyran derivatives in high yields within minutes at 55 degrees Celsius.]]></description>
										<content:encoded><![CDATA[<p>Chemists have long chased a deceptively simple goal: build complicated drug-like molecules quickly, cleanly, and without the heavy metal catalysts that often make industrial chemistry expensive and wasteful. A new study published in Results in Chemistry brings that goal a step closer. A team of researchers at the University of Mazandaran, led by Behrooz Maleki, reports that a single fluorinated alcohol, 1,1,1,3,3,3-hexafluoro-2-propanol, better known to chemists as HFIP, can act as both the reaction medium and the driving force for assembling tetrahydrobenzo[b]pyran derivatives in a one-pot, three-component reaction. No Lewis acid, no Brønsted acid, no metal salt, and no organocatalyst were added. The products emerged in yields as high as 95 percent within minutes at a modest 55 degrees Celsius.</p>
<p>The compounds at the center of the work, tetrahydrobenzo[b]pyrans and related 2-amino-3-cyano-4H-pyrans, belong to a family of oxygen-containing ring systems with an impressive portfolio of biological activities. Published studies have linked members of this class to anticancer, antimicrobial, antioxidant, anti-inflammatory, antiviral, anticoagulant, antidiabetic, analgesic, and spasmolytic effects. Beyond pharmacology, these fused pyran frameworks serve as versatile intermediates for constructing more elaborate heterocyclic architectures and functional organic materials. That combination of therapeutic relevance and synthetic utility explains why finding faster, greener ways to make them has become one of the busiest corners of modern heterocyclic chemistry.</p>
<p>The reaction the team exploited is a classic of multicomponent chemistry. An aromatic aldehyde, malononitrile, and a cyclic 1,3-dicarbonyl compound such as dimedone, or alternatively ethyl acetoacetate, are combined in a single flask. The domino sequence that follows proceeds through a Knoevenagel condensation, in which the aldehyde and malononitrile form an activated alkene, followed by a Michael addition of the enolized dicarbonyl compound, and finally an intramolecular cyclization that closes the pyran ring. Because three or more starting materials merge in one operation, multicomponent reactions of this type offer excellent atom economy, operational simplicity, high bond-forming efficiency, short reaction times, low energy consumption, and minimal waste, all hallmarks of green chemistry.</p>
<p>What has historically held this transformation back is the catalyst. Most reported protocols rely on Brønsted acids, Lewis acids, transition-metal complexes, ionic liquids, deep eutectic solvents, metal-organic frameworks, carbon-based materials, or recyclable magnetic nanocatalysts. Many of these systems deliver good yields, but they often demand laborious, multistep catalyst preparation, carry high costs, resist large-scale recycling, or require elevated temperatures, long reaction times, and environmentally undesirable organic solvents. The Iranian team&#8217;s answer was to strip the catalyst out entirely and let the solvent do the work.</p>
<p>HFIP is an unusual liquid. It is highly polar, weakly nucleophilic, and possesses an exceptional capacity to donate hydrogen bonds, along with very high ionizing power. Those properties allow it to stabilize cationic intermediates and polar transition states, activate carbonyl compounds, and facilitate proton transfers, all without being consumed or incorporated into the product. In recent years HFIP has attracted growing attention as a medium for cyclizations, electrophilic additions, carbon-hydrogen functionalization, oxidative transformations, and multicomponent processes, and mounting evidence suggests it can reduce or even eliminate the need for conventional acid catalysts. What had been missing, the authors note, was a demonstration of HFIP acting alone as the promoter for this particular pyran synthesis.</p>
<p>The optimization experiments tell a striking story. Using benzaldehyde, malononitrile, and dimedone as the model reaction, the researchers varied the amount of HFIP and the temperature. At room temperature with 0.30 milliliters of HFIP, the isolated yield reached 87 percent in just ten minutes. Raising the temperature to 55 degrees Celsius cut the time to five minutes and pushed the yield to 92 percent. Adding more HFIP brought no further benefit. Most tellingly, when HFIP was removed altogether, only a trace of product appeared after thirty minutes under otherwise identical conditions. Because the yield and rate climb with HFIP concentration, the authors interpret the effect as promotional rather than catalytic, and they are careful not to claim a catalytic turnover cycle without dedicated kinetic evidence.</p>
<p>The mechanistic picture the team offers, explicitly framed as a plausible hypothesis rather than experimentally confirmed proof, rests on hydrogen bonding. HFIP can hydrogen-bond to the carbonyl oxygen of the aldehyde, increasing the electrophilicity of the carbonyl carbon and thereby accelerating the initial Knoevenagel condensation with malononitrile. The same hydrogen-bonding network is thought to stabilize the charged intermediates that appear during the subsequent Michael addition and the intramolecular cyclization, allowing the entire domino sequence to run quickly and cleanly at relatively low temperature. The authors acknowledge that no specific kinetic experiments or comparative studies with alternative hydrogen-bond-donating solvents were performed, so the separate contribution of hydrogen bonding cannot yet be distinguished from other solvent effects.</p>
<p>With the optimized conditions in hand, the researchers surveyed a representative set of aromatic aldehydes bearing both electron-donating and electron-withdrawing substituents. Methoxy, chloro, and nitro groups were all tolerated. When dimedone served as the dicarbonyl component, the tetrahydrobenzo[b]pyran products were isolated in 91 to 95 percent yields over reaction times of roughly 90 to 100 minutes. Swapping dimedone for ethyl acetoacetate delivered the corresponding 2-amino-3-cyano-4H-pyran derivatives in 83 to 94 percent yields. The authors are candid about the limits: heteroaromatic aldehydes, sterically hindered substrates, and more electronically extreme cases were not systematically examined, so the results demonstrate reliable compatibility within the tested set rather than a universally broad substrate scope.</p>
<p>How does the HFIP protocol stack up against the competition? The team compared its results with representative literature procedures, including magnetic nanocatalysts operating under microwave irradiation or grinding, ammonium hydroxide in water, and urea in aqueous ethanol. For the benchmark products 4a through 4c, the HFIP method delivered 92 to 95 percent isolated yields at 55 degrees Celsius with reaction times similar to or shorter than most of the reference procedures, some of which required reflux, extended stirring, or elaborate catalyst synthesis. The comparison rests on reaction time and isolated yield alone, since parameters such as catalyst loading, solvent quantity, and recycling efficiency are not uniformly reported across studies. The clear advantage of the new protocol is its formulation: a homogeneous medium, a one-pot operation, mild temperature, and no added metal or acid catalyst, with products isolated by simple crystallization from ethanol rather than chromatography.</p>
<p>The authors also weigh the environmental ledger honestly. HFIP is a fluorinated solvent, and although it is readily distilled and was recovered by distillation for reuse in subsequent runs in the laboratory, the study did not experimentally evaluate recovery efficiency, energy costs, or solvent losses at scale. The environmental burden of fluorinated compounds, occupational hazards, and the energy required for solvent recovery all must be counted against the benefits of catalyst elimination, fast reactions, and high atom economy. The team concludes that the method is a valuable addition to the synthetic toolbox for the substrates tested, but that future work should expand the substrate scope, probe the mechanism with kinetic and comparative solvent studies, and rigorously assess HFIP recovery. For now, the message is clear and likely to resonate across medicinal chemistry and green synthesis alike: sometimes the most powerful catalyst in the flask is the solvent itself.</p>
<p><strong>Subject of Research:</strong> HFIP-promoted catalyst-free one-pot multicomponent synthesis of tetrahydrobenzo[b]pyran and 2-amino-3-cyano-4H-pyran derivatives</p>
<p><strong>Article Title:</strong> HFIP-promoted Lewis acid-free one-pot synthesis of pyran derivatives under mild conditions</p>
<p><strong>Article References:</strong> Nouri, F. Z., Maleki, B., Baharfar, R., Alinezhad, H., &amp; Ashrafi, S. S. (2026). HFIP-promoted Lewis acid-free one-pot synthesis of pyran derivatives under mild conditions. <em>Results in Chemistry, 31</em>, Article 103961. <a href="https://doi.org/10.1016/j.rechem.2026.103961" rel="noopener noreferrer">https://doi.org/10.1016/j.rechem.2026.103961</a></p>
<p><strong>Image Credits:</strong> AI Generated</p>
<p><strong>DOI:</strong> <a href="https://doi.org/10.1016/j.rechem.2026.103961" rel="noopener noreferrer">10.1016/j.rechem.2026.103961</a></p>
<p><strong>Keywords:</strong> HFIP, multicomponent reaction, pyran synthesis, green chemistry, hydrogen bonding, Knoevenagel condensation, Michael addition, heterocyclic chemistry, fluorinated solvents, catalyst-free synthesis, tetrahydrobenzo[b]pyrans, organic synthesis</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">258990</post-id>	</item>
		<item>
		<title>Magnetic Nickel Ferrite Nanocatalyst Slashes Synthesis Time for Valuable Drug-Like Molecules</title>
		<link>https://scienmag.com/magnetic-nickel-ferrite-nanocatalyst-slashes-synthesis-time-for-valuable-drug-like-molecules/</link>
		
		<dc:creator><![CDATA[Bethany Barker]]></dc:creator>
		<pubDate>Sat, 03 Oct 2026 00:08:02 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[applications of ortho-aminocarbonitrile]]></category>
		<category><![CDATA[catalyst design for accelerated chemical reactions]]></category>
		<category><![CDATA[catalyst recyclability]]></category>
		<category><![CDATA[environmentally friendly organic reaction techniques]]></category>
		<category><![CDATA[functionalization of heterocycles for pharmaceuticals]]></category>
		<category><![CDATA[green chemistry]]></category>
		<category><![CDATA[heterogeneous catalysis]]></category>
		<category><![CDATA[Knoevenagel condensation]]></category>
		<category><![CDATA[magnetic nanocatalyst for organic synthesis]]></category>
		<category><![CDATA[magnetic separation]]></category>
		<category><![CDATA[Michael addition]]></category>
		<category><![CDATA[multicomponent reaction]]></category>
		<category><![CDATA[nanocatalyst]]></category>
		<category><![CDATA[nanocatalysts for heterocyclic compound synthesis]]></category>
		<category><![CDATA[nanomaterials for electronic and optical applications]]></category>
		<category><![CDATA[nickel ferrite]]></category>
		<category><![CDATA[nickel ferrite nanocatalysts in chemistry]]></category>
		<category><![CDATA[rapid drug-like molecule production]]></category>
		<category><![CDATA[sustainable chemical manufacturing methods]]></category>
		<category><![CDATA[tetrahydronaphthalene]]></category>
		<category><![CDATA[triazine]]></category>
		<category><![CDATA[triazole]]></category>
		<category><![CDATA[ultrasound-assisted nanocatalyst synthesis]]></category>
		<category><![CDATA[use of ethanol and magnets in green chemistry]]></category>
		<guid isPermaLink="false">https://scienmag.com/?p=229751</guid>

					<description><![CDATA[Researchers have created a triazine-triazole-decorated magnetic nickel ferrite nanocatalyst that synthesizes ortho-aminocarbonitrile tetrahydronaphthalenes in up to 95 percent yield within ten minutes and can be magnetically recovered and reused for seven cycles.]]></description>
										<content:encoded><![CDATA[<p>Chemists at the University of Kashan have unveiled a new magnetic nanocatalyst that can build a family of industrially valuable organic molecules in as little as ten minutes, using nothing more exotic than ethanol, ultrasound, and a magnet. The material, described in the journal Results in Chemistry, is a nickel ferrite core wrapped in silica and decorated with nitrogen-rich triazine and triazole groups, and it promises to make the production of ortho-aminocarbonitrile tetrahydronaphthalenes faster, cleaner, and dramatically more sustainable than existing methods.</p>
<p>The molecules in question are far from obscure laboratory curiosities. Ortho-aminocarbonitrile tetrahydronaphthalenes are densely functionalized heterocycles featuring adjacent amino and nitrile groups on a partially saturated naphthalene ring. That combination gives them a rigid three-dimensional architecture, donor-acceptor electronic properties, and abundant handles for further chemical modification. They serve as precursors to dicyanoanilines, compounds prized for their optical and electronic behavior, and as building blocks for fluorescent systems, functional materials, and agents investigated for antiparasitic, anticancer, antioxidant, and antimicrobial activity. The cyano groups can be hydrolyzed to carboxylic acids or deployed in cyclization and reduction chemistry, while the amino group supports hydrogen bonding and nucleophilic transformations, making the scaffold a versatile launch point for medicinal and materials chemistry alike.</p>
<p>Traditionally, assembling such molecules requires multistep sequences that generate significant waste. The Kashan team instead turned to multicomponent reactions, or MCRs, a strategy in which three or more starting materials combine in a single operational step. MCRs are celebrated for their atom economy and operational simplicity, and they have become mainstays of drug discovery and green chemistry because they compress lengthy synthetic routes into one pot. In this work, the researchers combined cyclohexanone, malononitrile, and a range of substituted aromatic aldehydes, letting the catalyst orchestrate a cascade of bond-forming events that culminates in the fully assembled tetrahydronaphthalene framework.</p>
<p>The catalyst itself is a carefully engineered core-shell structure. The team began with nickel ferrite, NiFe2O4, nanoparticles produced by co-precipitating nickel nitrate and iron nitrate in a strongly alkaline solution at pH 13, stabilizing the particles with oleic acid, heating them at 80 degrees Celsius, and finally calcining them at 600 degrees Celsius to lock in a robust crystalline structure. Nickel ferrite was a deliberate choice: the material is known for strong magnetic properties, chemical stability, and proven catalytic performance across heterocycle synthesis, coupling reactions, oxidations, and reductions. A silica layer was then grafted onto the particles using 3-chloropropyl triethoxysilane in anhydrous toluene at 105 degrees Celsius, providing a chemically versatile surface that prevents the magnetic core from clumping.</p>
<p>Two further modification steps installed the catalytic engine. The chloro-functionalized surface reacted with 3-mercapto-1,2,4-triazole under reflux, introducing thiol-triazole functionalities, and a final coupling with cyanuric chloride at 110 degrees Celsius anchored triazine rings onto the scaffold. The resulting material, designated NiFe2O4@SiO2@TT, carries an abundance of basic nitrogen sites that drive the reaction chemistry, while the magnetic core allows the entire catalyst to be snatched out of solution with an ordinary external magnet rather than filtered or centrifuged. That simple recovery step eliminates catalyst loss and avoids energy-intensive separation techniques, a hallmark of green chemistry thinking.</p>
<p>Characterization confirmed the design worked as intended. X-ray diffraction showed the cubic spinel structure of the nickel ferrite core remained intact after functionalization, with reflections matching the reference pattern and no impurity phases. Applying the Scherrer equation to the broadened diffraction peaks gave an average crystallite size of roughly 26 nanometers. Field-emission scanning electron microscopy resolved discrete particles between 27 and 33 nanometers, forming porous aggregates of 120 to 280 nanometers, a hierarchical structure that enhances mass transport and exposes reactive sites. Energy-dispersive X-ray spectroscopy and elemental mapping verified the presence and even distribution of iron, nickel, silicon, carbon, nitrogen, and sulfur throughout the composite.</p>
<p>Other measurements filled in the picture of a material built for demanding service. Vibrating sample magnetometry recorded a saturation magnetization of 23.8 emu per gram, ample for swift magnetic extraction. Nitrogen adsorption analysis revealed a Type IV isotherm typical of mesoporous materials, with a BET surface area of 50.8 square meters per gram and a bimodal pore distribution combining micropores, which boost surface area, with larger mesopores that ease molecular traffic to active sites. Thermogravimetric analysis showed a total weight loss of just 9.8 percent up to 800 degrees Celsius, with the organic functional groups decomposing around 340 degrees Celsius, confirming the hybrid framework remains thermally stable under realistic reaction conditions.</p>
<p>Performance testing delivered striking numbers. After optimizing solvent, temperature, and catalyst loading, the team found that just 5 milligrams of the nanocatalyst in refluxing ethanol converted the model reaction mixture to product in 95 percent yield within ten minutes. Toluene, by contrast, gave the worst results, while ethanol&#8217;s polarity proved ideal for shuttling reactants to the catalyst&#8217;s active sites. The protocol then swept through sixteen different aromatic aldehydes bearing electron-donating and electron-withdrawing substituents, including chloro, bromo, fluoro, nitro, methyl, hydroxy, methoxy, and dimethylamino groups. Every substrate delivered its product in 86 to 95 percent yield within ten to twenty minutes, demonstrating broad substrate tolerance and practical reliability. Turnover frequencies reached as high as 397 per hour.</p>
<p>The proposed mechanism reads like a molecular relay race. Basic sites on the catalyst first deprotonate malononitrile and promote a Knoevenagel condensation with cyclohexanone, generating an unsaturated intermediate after dehydration. In parallel, another malononitrile molecule condenses with the aromatic aldehyde to form an arylidene malononitrile. The two fragments then meet in a Michael-type addition, followed by intramolecular cyclization, proton transfer, and catalyst-assisted tautomerization that delivers the final tetrahydronaphthalene while regenerating the catalyst for the next cycle. A hot filtration test, in which the catalyst was removed at roughly half conversion, showed no further product formation in the filtrate, proving the activity truly resides on the solid surface rather than in leached species. ICP-OES analysis quantified metal leaching at less than 0.004 percent for nickel and 0.007 percent for iron.</p>
<p>Perhaps most impressively, the catalyst survived seven consecutive reaction cycles with only marginal loss of activity, and post-use FE-SEM, FT-IR, XRD, and VSM analyses confirmed its morphology and structure were essentially unchanged. Compared with previously reported systems, which required anywhere from an hour to a full day and sometimes costly ionic liquids or stoichiometric organic bases, the new protocol matches or beats the best yields in a fraction of the time. A green chemistry assessment using the ComplexMoGAPI metric credited the method&#8217;s one-pot design, low catalyst loading, short reaction time, ethanol solvent, and magnetic recyclability. The researchers suggest their strategy of marrying functionalized magnetic supports with nitrogen-rich active groups could inspire similar platforms for other catalytic transformations, pointing toward a future where complex drug-like molecules are assembled quickly, cleanly, and with a magnet doing the cleanup.</p>
<p><strong>Subject of Research:</strong> Development of a triazine-triazole functionalized magnetic nickel ferrite silica nanocatalyst for the green multicomponent synthesis of ortho-aminocarbonitrile tetrahydronaphthalene derivatives</p>
<p><strong>Article Title:</strong> Triazine-triazole decorated magnetic nickel ferrite as a novel nanocatalyst for green synthesis of ortho-aminocarbonitrile tetrahydronaphthalenes</p>
<p><strong>Article References:</strong> Mohammadi, M., Khorasani, M., &amp; Naeimi, H. (2026). Triazine-triazole decorated magnetic nickel ferrite as a novel nanocatalyst for green synthesis of ortho-aminocarbonitrile tetrahydronaphthalenes. <em>Results in Chemistry, 31</em>, Article 103859. <a href="https://doi.org/10.1016/j.rechem.2026.103859" rel="noopener noreferrer">https://doi.org/10.1016/j.rechem.2026.103859</a></p>
<p><strong>Image Credits:</strong> AI Generated</p>
<p><strong>DOI:</strong> <a href="https://doi.org/10.1016/j.rechem.2026.103859" rel="noopener noreferrer">10.1016/j.rechem.2026.103859</a></p>
<p><strong>Keywords:</strong> nanocatalyst, nickel ferrite, magnetic separation, multicomponent reaction, green chemistry, tetrahydronaphthalene, heterogeneous catalysis, triazine, triazole, Knoevenagel condensation, Michael addition, catalyst recyclability</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">229751</post-id>	</item>
		<item>
		<title>New Oligophenyl Vinyl Molecule Shows Antioxidant and Anti-Inflammatory Power</title>
		<link>https://scienmag.com/new-oligophenyl-vinyl-molecule-shows-antioxidant-and-anti-inflammatory-power/</link>
		
		<dc:creator><![CDATA[Bethany Barker]]></dc:creator>
		<pubDate>Thu, 01 Oct 2026 12:36:16 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[alpha-amylase]]></category>
		<category><![CDATA[alpha-glucosidase]]></category>
		<category><![CDATA[anti-inflammatory]]></category>
		<category><![CDATA[antidiabetic]]></category>
		<category><![CDATA[antioxidant]]></category>
		<category><![CDATA[antioxidant and anti-inflammatory drug potential]]></category>
		<category><![CDATA[bioassay and computational analysis in drug discovery]]></category>
		<category><![CDATA[CNR2]]></category>
		<category><![CDATA[DPPH assay]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[enzyme inhibition for type 2 diabetes]]></category>
		<category><![CDATA[Free radical scavenging activity]]></category>
		<category><![CDATA[Knoevenagel condensation]]></category>
		<category><![CDATA[molecular docking]]></category>
		<category><![CDATA[molecular docking and dynamics studies]]></category>
		<category><![CDATA[molecular dynamics]]></category>
		<category><![CDATA[multifunctional drug design from aromatic frameworks]]></category>
		<category><![CDATA[novel organic compounds for health applications]]></category>
		<category><![CDATA[oligophenyl vinyl]]></category>
		<category><![CDATA[Oligophenyl vinyl molecule synthesis]]></category>
		<category><![CDATA[organic molecules with therapeutic and material science relevance]]></category>
		<category><![CDATA[protein denaturation inhibition]]></category>
		<category><![CDATA[simple Knoevenagel condensation synthesis]]></category>
		<category><![CDATA[structure-activity relationship of oligophenyl derivatives]]></category>
		<guid isPermaLink="false">https://scienmag.com/?p=222710</guid>

					<description><![CDATA[Chemists in India have synthesized a simple oligophenyl vinyl compound, CNR2, that matches vitamin C as an antioxidant and diclofenac as an anti-inflammatory agent in vitro while showing moderate antidiabetic enzyme inhibition supported by docking and simulation studies.]]></description>
										<content:encoded><![CDATA[<p>A team of chemists and pharmaceutical scientists in India has synthesized a small organic molecule that, in laboratory tests, neutralizes free radicals and blocks protein denaturation almost as effectively as established reference compounds, while also showing measurable activity against the carbohydrate-digesting enzymes implicated in type 2 diabetes. The compound, designated CNR2, belongs to a family of structures known as oligophenyl vinyl frameworks, and the new study published in Discover Chemistry suggests that this scaffold, long valued for its optical properties in materials science, may deserve a second career as a starting point for multifunctional drug design. The work, led by researchers at Goa University together with collaborators at the Central University of Kalaburagi, the Institute of Chemical Technology, Goa College of Pharmacy and colleges in Maharashtra, combined classical wet-laboratory bioassays with molecular docking and molecular dynamics simulations to build a picture of how the molecule interacts with its biological targets.</p>
<p>The synthesis itself is strikingly simple, which is one reason the finding could attract broad attention. CNR2, formally named (2Z,2&#8217;Z)-2,2&#8242;-(1,4-phenylene)bis(3-(pyridin-2-yl)acrylonitrile), was produced by a Knoevenagel condensation, a reaction in which picolinaldehyde and 1,4-phenylene diacetonitrile are heated in methanol at 60 degrees Celsius for 24 hours in the presence of the base pyrrolidine. After filtration and washing with methanol, the product emerged as a yellow powder in quantitative yield, meaning essentially all of the starting material was converted into the desired compound. The product was confirmed by proton and carbon-13 nuclear magnetic resonance spectroscopy, with the spectra recorded in deuterated DMSO on Bruker instruments. This ease of preparation matters for medicinal chemistry because scaffolds that can be assembled cheaply and modified readily allow rapid exploration of structure-activity relationships, the systematic tweaking of molecular features to improve potency and selectivity.</p>
<p>The antioxidant evaluation relied on the DPPH free radical scavenging assay, a widely used colorimetric test in which the purple DPPH radical loses absorbance at 517 nanometers as it is reduced by an antioxidant. The researchers tested CNR2 at concentrations ranging from 20 to 100 micrograms per milliliter and calculated the concentration needed to inhibit fifty percent of radical activity, the IC50 value. CNR2 achieved an IC50 of 34.26 plus or minus 0.34 micrograms per milliliter, essentially indistinguishable from ascorbic acid, the standard antioxidant, which scored 33.50 plus or minus 0.33 micrograms per milliliter under identical conditions. At the highest concentration tested, both compounds scavenged nearly ninety-nine percent of the free radicals present. The authors also compared the result with their earlier compound CNR3, reported in the Journal of Molecular Structure, which had an IC50 of 48.40 micrograms per milliliter; the new molecule is clearly the stronger antioxidant of the pair, an improvement the team attributes to the pyridine-bearing architecture of CNR2.</p>
<p>Anti-inflammatory activity was assessed through a modified protein denaturation inhibition assay. Protein denaturation, the unfolding of the secondary and tertiary structures of proteins, is considered a hallmark of inflammatory damage, and compounds that prevent it are regarded as candidates for anti-inflammatory therapy. In the modified protocol, bovine serum albumin was mixed with test compound and phosphate-buffered saline, incubated at 37 degrees Celsius, then heated to 70 degrees Celsius to force denaturation. Rather than measuring turbidity as in the conventional assay, the team applied Lowry&#8217;s protein estimation reagents, including alkaline copper reagent and Folin-Ciocalteu reagent, so that greater unfolding exposes more peptide bonds and produces stronger color development, read at 650 nanometers. Against this benchmark, CNR2 posted an IC50 of 34.83 plus or minus 0.66 micrograms per milliliter, virtually identical to the clinical anti-inflammatory drug diclofenac sodium at 34.74 plus or minus 0.82 micrograms per milliliter. Once again the new scaffold outperformed its predecessor CNR3, which had reached only 42.78 micrograms per milliliter in the earlier study.</p>
<p>The antidiabetic results were more nuanced. The team measured the ability of CNR2 to inhibit two enzymes central to carbohydrate digestion, alpha-amylase and alpha-glucosidase, using the DNSA colorimetric method for the former and a p-nitrophenyl-alpha-D-glucopyranoside substrate assay read at 405 nanometers for the latter. CNR2 inhibited alpha-amylase with an IC50 of 51.69 plus or minus 0.24 micrograms per milliliter, weaker than the standard drug acarbose at 38.28 plus or minus 0.14 micrograms per milliliter. Against alpha-glucosidase, CNR2 reached an IC50 of 33.19 plus or minus 0.73 micrograms per milliliter, while acarbose achieved a markedly better 16.29 plus or minus 0.18 micrograms per milliliter. Even so, CNR2 improved on CNR3 in both assays, and the authors characterize its antidiabetic profile as moderate rather than weak, positioning the molecule as a lead structure awaiting optimization rather than a finished drug candidate.</p>
<p>To understand why the molecule behaves the way it does, the researchers turned to computational structural biology. They docked CNR2 into the active site of alpha-amylase from barley, Hordeum vulgare, using the crystal structure deposited in the Protein Data Bank under the identifier 1RPK, and into a predicted structure of alpha-glucosidase from baker&#8217;s yeast, Saccharomyces cerevisiae, generated with the AlphaFold server. Protein preparation was carried out in UCSF Chimera, ligand preparation in OpenBabel, and docking with AutoDock Vina. The docking results revealed a rich network of non-covalent contacts: with alpha-amylase, CNR2 formed hydrogen bonds with the residues Arg183 and Asn209 and engaged in pi-stacking with the aromatic side chains of Trp207 and Trp299; with alpha-glucosidase it hydrogen-bonded to His239 and Arg439 and pi-stacked with Tyr71 and His279. These interactions are precisely the kind that the extended sp2-conjugated framework of an oligophenyl vinyl system is designed to deliver, since the flat, rigid geometry of the molecule favors pi-pi stacking and hydrophobic contacts inside enzyme pockets.</p>
<p>Molecular dynamics simulations running for 100 nanoseconds then tested whether the docked complexes would remain stable in a realistic, fluctuating environment. Root-mean-square deviation and root-mean-square fluctuation analyses indicated that the protein-inhibitor complexes held together over the simulation time, with the ligand remaining in the active site for most of the trajectory. One instructive difference emerged between the two enzymes: alpha-glucosidase possesses a larger binding pocket than alpha-amylase, and within that roomier cavity CNR2 displayed greater positional freedom, registering higher ligand displacement. The comparison of interaction maps before and after simulation showed a rearrangement of contacts, with the alpha-amylase complex shifting from interactions dominated by Phe144, Phe181, Arg183, Trp207, Asn209, Met210 and Trp299 toward a network involving Tyr71, Phe157, Phe158, Arg439, Phe300, His239, His279 and Pro309, evidence that the molecule explores its binding site dynamically rather than locking into a single pose.</p>
<p>What makes the study conceptually interesting is the convergence of two research traditions. Oligophenyl vinylene frameworks have historically been prized in optoelectronics, where their fluorescence, high quantum yields and chemical stability have made them useful in organic light-emitting diodes, sensors and other devices, including fluorescent probes for detecting cyanide ions. The rigid geometry of these molecules pre-organizes them for target binding and reduces the entropic cost of complex formation, while their extended conjugation enables tunable photophysics and strong stacking interactions. The new work extends that logic into pharmacology, arguing that the same structural features that make OPV materials good emitters also make them competent ligands for enzyme active sites and effective radical scavengers. The authors suggest that heteroatoms such as the pyridine nitrogens, with their lone-pair electrons, facilitate hydrogen bonding and coordination, further broadening the scaffold&#8217;s interaction repertoire.</p>
<p>The team is careful about the limits of the evidence. All biological results come from in vitro assays performed in triplicate and analyzed statistically with one-way ANOVA and Dunnett&#8217;s post hoc testing, with significance set at a p value below 0.01. There are, as yet, no animal or cellular studies, no toxicity profiling, no pharmacokinetic measurements and no detailed mechanistic experiments in living systems, all of which would be required before any therapeutic claim could be entertained. The authors state plainly that the moderate antidiabetic activity, combined with favorable docking interactions, points toward further structural optimization rather than immediate clinical relevance, and that advanced cellular and animal models are necessary to validate both the pharmacological potential and the safety profile of CNR2.</p>
<p>Even with those caveats, the paper offers a clean demonstration of how a readily synthesized, optically versatile scaffold can be repurposed as a multifunctional bioactive molecule. A single compound that scavenges radicals like vitamin C, protects proteins from denaturation like diclofenac, and inhibits digestive enzymes at measurable potency, all from a one-pot reaction in methanol, is exactly the kind of versatile starting point that medicinal chemists seek. Whether CNR2 or its descendants will survive the long road from a cuvette to a clinic remains an open question, but the study establishes the oligophenyl vinyl framework as a credible platform for the design of next-generation antioxidant, anti-inflammatory and antidiabetic agents.</p>
<p><strong>Subject of Research:</strong> Bioactivity and molecular interactions of a synthetic oligophenyl vinyl compound with antioxidant, anti-inflammatory, and antidiabetic properties</p>
<p><strong>Article Title:</strong> Discovery of a bioactive oligophenyl vinyl scaffold with anti-inflammatory, antidiabetic, and antioxidant potential</p>
<p><strong>Article References:</strong> Khobrekar, P. P., Gawade, V. K., Barretto, D. A., Maliwal, D., Pissurlenkar, R. R. S., More, V. S., Bugde, S. T., Bhosale, S. V., &amp; Jadhav, R. W. (2026). Discovery of a bioactive oligophenyl vinyl scaffold with anti-inflammatory, antidiabetic, and antioxidant potential. <em>Discover Chemistry, 3</em>(1), Article 549. <a href="https://doi.org/10.1007/s44371-026-01001-z" rel="noopener noreferrer">https://doi.org/10.1007/s44371-026-01001-z</a></p>
<p><strong>Image Credits:</strong> AI Generated</p>
<p><strong>DOI:</strong> <a href="https://doi.org/10.1007/s44371-026-01001-z" rel="noopener noreferrer">10.1007/s44371-026-01001-z</a></p>
<p><strong>Keywords:</strong> oligophenyl vinyl, CNR2, antioxidant, anti-inflammatory, antidiabetic, DPPH assay, alpha-amylase, alpha-glucosidase, molecular docking, molecular dynamics, Knoevenagel condensation, drug discovery</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">222710</post-id>	</item>
		<item>
		<title>Kitchen Chemistry: Lemon Juice Powers Greener Route to Drug-Like Molecules</title>
		<link>https://scienmag.com/kitchen-chemistry-lemon-juice-powers-greener-route-to-drug-like-molecules/</link>
		
		<dc:creator><![CDATA[Bethany Barker]]></dc:creator>
		<pubDate>Thu, 01 Oct 2026 11:20:59 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[4-hydroxycoumarin]]></category>
		<category><![CDATA[barbituric acid]]></category>
		<category><![CDATA[bio-based catalysis in organic chemistry]]></category>
		<category><![CDATA[chromene]]></category>
		<category><![CDATA[chromenopyrimidine]]></category>
		<category><![CDATA[cost-effective green chemistry techniques]]></category>
		<category><![CDATA[eco-friendly heterocyclic compound production]]></category>
		<category><![CDATA[environmentally friendly drug molecule synthesis]]></category>
		<category><![CDATA[green chemistry]]></category>
		<category><![CDATA[green methods in medicinal chemistry]]></category>
		<category><![CDATA[Knoevenagel condensation]]></category>
		<category><![CDATA[lemon juice]]></category>
		<category><![CDATA[lemon juice as biodegradable catalyst]]></category>
		<category><![CDATA[metal-free catalysis]]></category>
		<category><![CDATA[multicomponent reaction]]></category>
		<category><![CDATA[natural catalyst in drug synthesis]]></category>
		<category><![CDATA[one-pot multi-component reactions]]></category>
		<category><![CDATA[organocatalysis]]></category>
		<category><![CDATA[plant-derived catalysts in pharmaceuticals]]></category>
		<category><![CDATA[safer alternatives to metal catalysts]]></category>
		<category><![CDATA[salicylaldehyde]]></category>
		<category><![CDATA[sustainable chemical synthesis]]></category>
		<category><![CDATA[sustainable synthesis]]></category>
		<guid isPermaLink="false">https://scienmag.com/?p=222322</guid>

					<description><![CDATA[Indian chemists have used ordinary lemon juice as a natural acid catalyst to build biologically important chromene-fused molecules in a one-pot, metal-free reaction with high yields and simple purification.]]></description>
										<content:encoded><![CDATA[<p>In a development that sounds almost too simple to be true, chemists in India have shown that ordinary lemon juice—the same stuff squeezed over salads and into tea—can drive the synthesis of complex, drug-like molecules that usually demand expensive metal catalysts and hazardous solvents. The study, published in Discover Green Chemistry, describes a one-pot, three-component reaction in which lemon juice acts as a natural, biodegradable catalyst to build two families of fused heterocyclic compounds: chromeno[4,3-b]chromenes and chromeno[2,3-d]pyrimidines. These scaffolds sit at the heart of numerous biologically active molecules, and the new protocol offers a cleaner, cheaper, and more accessible way to make them than most existing methods.</p>
<p>The research team, led by Yogesh Bhaskar Singh Tanwer, Suman Sourabh, and Sabyasachi Bhunia of the Central University of Jharkhand, together with Sanchari Pal and Debjit Das of Triveni Devi Bhalotia College, combined three simple ingredients in a single flask: a substituted salicylaldehyde, either 4-hydroxycoumarin or 1,3-dimethylbarbituric acid, and an electron-rich arene such as 1,3,5-trimethoxybenzene. Heating this mixture at 90 degrees Celsius in a mixture of lemon juice and ethanol produced the desired fused chromene products in yields ranging from 74 to 87 percent for the chromeno[4,3-b]chromene series and good to excellent yields for the chromeno[2,3-d]pyrimidine analogues. No metals, no exotic reagents, no chromatographic purification—just filtration and a wash with aqueous ethanol in most cases.</p>
<p>The appeal of multicomponent reactions lies in their efficiency. Rather than assembling a target molecule step by step, isolating and purifying intermediates at each stage, a multicomponent reaction stitches three or more building blocks together in one operation. This convergence saves time, energy, solvent, and manpower, which is why such reactions are prized in pharmaceutical and combinatorial chemistry. But traditional versions of these reactions often rely on volatile organic solvents and toxic or costly metal catalysts, undermining their green credentials. The Indian team&#8217;s approach sidesteps both problems by using a food-derived catalyst in a largely benign medium.</p>
<p>Lemon juice has been attracting growing attention as a biocatalyst in recent years. It is cheap, widely available, water-soluble, biodegradable, and non-toxic, and its natural acidity—derived primarily from citric acid—allows it to substitute for harmful metallic and non-metallic acid catalysts in a range of organic transformations. In the new study, the researchers found that lemon juice alone in water failed to deliver any product even after 24 hours of reflux, largely because the organic starting materials dissolve poorly in the aqueous juice. Adding ethanol as a co-solvent solved the solubility problem dramatically: with 2.0 milliliters of lemon juice and 1.5 milliliters of ethanol at 90 degrees Celsius, the model reaction between salicylaldehyde, 1,3,5-trimethoxybenzene, and 4-hydroxycoumarin delivered the product 4a in 89 percent yield.</p>
<p>With the optimized conditions in hand, the team explored how broadly the method could be applied. A variety of salicylaldehyde derivatives reacted smoothly with 1,3,5-trimethoxybenzene and 4-hydroxycoumarin, furnishing nine different chromeno[4,3-b]chromene products in 74 to 87 percent yields. Switching the coumarin component for 1,3-dimethylbarbituric acid redirected the chemistry toward chromeno[2,3-d]pyrimidines, seven derivatives of which were obtained in good to excellent yields. The researchers also demonstrated that dibenzylaniline, another strongly electron-rich arene, could serve as the arene component, giving the corresponding products in good yields, including a chromeno[2,3-d]pyrimidine in 78 percent yield.</p>
<p>The substrate scope does have a clear boundary. The reaction tolerates a range of substituents on the salicylaldehyde ring, but it works only with strongly electron-rich arenes. Weaker candidates such as mesitylene, dimethoxybenzene, and methoxynaphthalene showed little to no activity, a limitation that reflects the electrophilic character of the key intermediate in the reaction pathway. Even so, the products obtained represent a class of compounds that had not previously been accessible through a general protocol using direct arene functionalization at the 7 and 5 positions, making the method a genuine addition to the synthetic toolbox.</p>
<p>To understand how the reaction actually works, the team ran a series of control experiments. When salicylaldehyde and 1,3,5-trimethoxybenzene were heated together without the coumarin component, no adduct formed, ruling out a direct coupling pathway. When salicylaldehyde and 4-hydroxycoumarin were combined under the optimized conditions, a condensed product—labeled intermediate B—formed in 66 percent yield within six hours. The researchers isolated this intermediate, confirmed its structure by nuclear magnetic resonance spectroscopy, and then showed that reacting it with 1,3,5-trimethoxybenzene gave the final chromeno[4,3-b]chromene in 91 percent yield. This established that the three-component reaction proceeds through intermediate B rather than through a different sequence.</p>
<p>Based on these observations, the authors proposed a plausible mechanism. The acidity of the lemon juice first promotes a Knoevenagel condensation between the salicylaldehyde and the 4-hydroxycoumarin, generating the electron-poor Michael acceptor B. The electron-rich arene then adds to this acceptor in a Michael-type addition, producing an intermediate containing a tertiary carbon center. Finally, an acid-driven intramolecular ring closure followed by dehydration delivers the fused chromene product. In other words, the citric acid in the juice orchestrates every key step of the cascade, from initial condensation to final cyclization, without any metal assistance.</p>
<p>Practical considerations further strengthen the case for the method. The structures of two representative products were unambiguously confirmed by single-crystal X-ray crystallographic analysis, and all compounds were characterized by proton and carbon NMR spectroscopy, high-resolution mass spectrometry, and elemental analysis. Crucially, the team demonstrated that the reaction can be scaled up: a 10-millimole-scale run of the model compound proceeded with effectiveness and yields comparable to the small-scale experiments, suggesting genuine potential for commercial and industrial application. Because nearly all products precipitate from the reaction mixture, purification requires only filtration and washing, eliminating extraction steps, column chromatography, and the large volumes of harmful organic solvents they consume.</p>
<p>The significance of the work extends beyond the specific molecules made. Chromene derivatives are distributed widely in natural products, drugs, and edible plants, and their fused hybrids with coumarin or barbituric acid units display a striking range of pharmacological activities, including antitumor, anti-inflammatory, cytotoxic, antioxidant, antithrombotic, and antiplatelet effects, along with useful photophysical properties. A hybrid framework combining chromene with other bioactive analogues may incorporate the characteristics of both and enhance biological activity, which is precisely why synthetic chemists keep seeking better ways to build them. By replacing toxic metals and hazardous solvents with a kitchen staple, the Indian team has shown that the principles of green chemistry—waste prevention, safer solvents, catalysis, and energy efficiency—can be honored without sacrificing yield, scope, or scalability. The study was funded by the Science and Engineering Research Board and the University Grants Commission of India, and it stands as a vivid reminder that sometimes the most sustainable catalyst is sitting in the refrigerator.</p>
<p><strong>Subject of Research:</strong> Lemon juice-mediated green synthesis of chromeno[4,3-b]chromene and chromeno[2,3-d]pyrimidine derivatives via one-pot three-component reactions</p>
<p><strong>Article Title:</strong> Lemon juice mediated environmentally benign synthesis of functionalized chromeno[4,3-b]chromene/chromeno[2,3‐d]pyrimidine derivatives via one-pot three component reaction</p>
<p><strong>Article References:</strong> Lemon juice mediated environmentally benign synthesis of functionalized chromeno[4,3-b]chromene/chromeno[2,3‐d]pyrimidine derivatives via one-pot three component reaction. (n.d.). <a href="https://doi.org/10.1007/s44509-026-00001-7" rel="noopener noreferrer">https://doi.org/10.1007/s44509-026-00001-7</a></p>
<p><strong>Image Credits:</strong> AI Generated</p>
<p><strong>DOI:</strong> <a href="https://doi.org/10.1007/s44509-026-00001-7" rel="noopener noreferrer">10.1007/s44509-026-00001-7</a></p>
<p><strong>Keywords:</strong> lemon juice, green chemistry, multicomponent reaction, chromene, chromenopyrimidine, organocatalysis, salicylaldehyde, 4-hydroxycoumarin, barbituric acid, Knoevenagel condensation, sustainable synthesis, metal-free catalysis</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">222322</post-id>	</item>
		<item>
		<title>Recyclable Acid Catalyst Powers Greener Solvent-Free Route to Drug-Like Molecules</title>
		<link>https://scienmag.com/recyclable-acid-catalyst-powers-greener-solvent-free-route-to-drug-like-molecules/</link>
		
		<dc:creator><![CDATA[Bethany Barker]]></dc:creator>
		<pubDate>Thu, 01 Oct 2026 09:39:05 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[advances in eco-friendly drug discovery methods]]></category>
		<category><![CDATA[Brønsted acid catalysis]]></category>
		<category><![CDATA[catalyst recyclability]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[environmentally friendly routes to polyhydroquinoline derivatives]]></category>
		<category><![CDATA[green chemistry]]></category>
		<category><![CDATA[green chemistry approaches in pharmaceutical manufacturing]]></category>
		<category><![CDATA[Hantzsch reaction]]></category>
		<category><![CDATA[heterocyclic chemistry]]></category>
		<category><![CDATA[Knoevenagel condensation]]></category>
		<category><![CDATA[moderate temperature catalytic reactions for pharmaceutical compounds]]></category>
		<category><![CDATA[multicomponent reactions]]></category>
		<category><![CDATA[pentafluorophenylammonium triflate in organic synthesis]]></category>
		<category><![CDATA[PFPAT]]></category>
		<category><![CDATA[polyhydroquinolines]]></category>
		<category><![CDATA[recovery and reuse of acid catalysts in]]></category>
		<category><![CDATA[Recyclable Brønsted acid catalyst for solvent-free drug-like molecule synthesis]]></category>
		<category><![CDATA[single-pot synthesis of nitrogen-containing ring systems]]></category>
		<category><![CDATA[solvent-free catalytic processes for medicinal chemistry]]></category>
		<category><![CDATA[solvent-free synthesis]]></category>
		<category><![CDATA[sustainable synthesis]]></category>
		<category><![CDATA[sustainable synthesis of biologically active heterocycles]]></category>
		<guid isPermaLink="false">https://scienmag.com/?p=221794</guid>

					<description><![CDATA[Researchers report a solvent-free, one-pot Hantzsch synthesis of biologically important polyhydroquinoline derivatives using a recyclable Brønsted acid catalyst that delivers yields up to 94 percent.]]></description>
										<content:encoded><![CDATA[<p>Chemists in India have unveiled a cleaner, faster way to build a family of molecules that sit at the heart of many drug-discovery programs. In a study published in Discover Chemistry, Prasad Pande, Kirti Niralwad and Abhijeet Patki report that a recyclable Brønsted acid called pentafluorophenylammonium triflate, or PFPAT, can drive the synthesis of polyhydroquinoline derivatives in a single pot, without any solvent, at moderate temperature, and in yields reaching 94 percent. The work addresses a long-standing tension in synthetic chemistry: the compounds themselves are biologically precious, but the traditional ways of making them often rely on harsh conditions, toxic solvents and catalysts that are difficult or impossible to recover.</p>
<p>Polyhydroquinolines are not laboratory curiosities. These nitrogen-containing ring systems, close cousins of the dihydropyridine scaffolds found in calcium-channel blockers, have been linked to an impressive range of pharmacological activities, including hepatoprotective, antidiabetic, geroprotective, bronchodilator, vasodilator, antiatherosclerotic and antitumor effects. Related structures have also shown antiplasmodial, antibacterial and antimalarial activity. Because of this versatility, medicinal chemists have spent decades searching for efficient ways to assemble them, and the classic route traces all the way back to 1882, when Arthur Hantzsch first described a one-pot condensation of an aldehyde, a beta-ketoester and ammonia in acetic acid or ethanol.</p>
<p>The Hantzsch reaction is a prime example of a multicomponent reaction, a strategy in which three or more starting materials combine in a single step to form a product that incorporates most of the atoms of the reactants. Multicomponent reactions are prized for their atom economy and for slashing the number of synthetic steps required to reach complex heterocyclic scaffolds. Yet many modern versions of the polyhydroquinoline synthesis still carry baggage: metal salts that complicate separation, ionic liquids that are costly, catalysts that cannot be reused, or solvents that generate waste. The new study set out to strip away as much of that baggage as possible.</p>
<p>The researchers&#8217; catalyst of choice, PFPAT, is a non-metallic organoammonium salt whose design is deceptively simple but chemically clever. The strongly electron-withdrawing pentafluorophenyl group, paired with a weakly coordinating triflate anion, makes the ammonium proton unusually acidic. That acidity allows PFPAT to activate carbonyl compounds through proton transfer and hydrogen-bonding interactions, the key first move in the multicomponent condensation. Because the catalyst is a metal-free organic salt, it avoids many of the separation and recyclability problems that plague soluble metal catalysts, particularly when reactions are scaled up.</p>
<p>The model reaction combined benzaldehyde, ethyl acetoacetate, dimedone and ammonium acetate, with reaction progress tracked by thin-layer chromatography. Without any catalyst, the mixture yielded only trace product even after prolonged reaction, and heating to 90 degrees Celsius alone brought only marginal improvement, a clear sign that thermal activation is not enough. When PFPAT was introduced, the picture changed dramatically. Raising the catalyst loading from 2.5 to 10 mole percent steadily improved both yield and reaction time, and 10 mole percent at 90 degrees Celsius emerged as the optimum. Pushing the loading further, to 12.5 or 15 mole percent, offered no meaningful benefit, indicating that the active catalytic sites were already sufficient for efficient conversion.</p>
<p>Solvent screening reinforced the green credentials of the protocol. The team tested acetonitrile, chloroform, dimethyl sulfoxide and dichloromethane, and even the best performer, DMSO, managed only a moderate 68 percent yield with longer reaction times. Nothing matched the solvent-free system. Under the optimized conditions, the model product was isolated in 86 percent yield in just three hours, with the crude solid obtained by simple filtration, washed with a minimal volume of ethyl acetate and petroleum ether, and purified by recrystallization from hot aqueous ethanol. The work-up is deliberately mundane, which is precisely the point for a procedure intended to be practical.</p>
<p>To benchmark PFPAT against the competition, the researchers ran the same model reaction with a lineup of commercially available Lewis and Brønsted acid catalysts under identical conditions. Metal salts such as zinc chloride, iron(III) chloride and iron(III) iodide delivered conversions of only 60 to 72 percent with isolated yields of 38 to 50 percent. The lanthanide triflate La(OTf)3 fared better at 85 percent conversion and 65 percent yield, while p-toluenesulfonic acid and heterogeneous titanium dioxide pushed past 90 percent conversion with yields above 70 percent over five hours. PFPAT outperformed them all, achieving complete conversion and an 86 percent yield in three hours. Calculated turnover numbers told the same story: PFPAT posted the highest TON of 8.6 and TOF of 2.87 per hour among the catalysts tested, reflecting its strong Brønsted acidity and its knack for accelerating the cyclocondensation under mild, solvent-free conditions.</p>
<p>The substrate scope revealed a clear and chemically satisfying pattern. Eleven substituted benzaldehydes were converted into their polyhydroquinoline products, spanning electron-donating groups such as methyl, methoxy and hydroxy as well as electron-withdrawing halogens and nitro groups. Electron-poor aldehydes reacted fastest and best: 4-nitrobenzaldehyde gave its product in 94 percent yield within just 1.5 hours, while electron-rich 4-methoxybenzaldehyde needed four hours and delivered 78 percent. The explanation lies in the first step of the mechanism, a Knoevenagel condensation in which the aldehyde carbonyl must be attacked. Electron-withdrawing substituents make the carbonyl carbon more electrophilic, speeding both the condensation and the subsequent cyclization, whereas electron-donating groups dampen electrophilicity and slow the cascade. The consistent trend across substrates suggests the catalytic system has a general affinity for electron-deficient aromatic aldehydes, a useful guide for anyone planning to apply the method.</p>
<p>Mechanistically, the reaction unfolds as a classic Hantzsch-type sequence. PFPAT first activates the aldehyde carbonyl through hydrogen bonding and acid interactions, priming it for nucleophilic attack. Ammonium acetate then reacts with ethyl acetoacetate to generate an enamine intermediate, while dimedone undergoes a PFPAT-catalyzed Knoevenagel condensation with the activated aldehyde to form a reactive alpha,beta-unsaturated intermediate. The enamine adds to this activated olefin in a Michael-type addition, followed by intramolecular cyclization and tautomerization to close the polyhydroquinoline ring. The catalyst&#8217;s ability to promote proton transfers and stabilize charged intermediates through each of these stages is what allows the whole cascade to proceed smoothly without solvent.</p>
<p>Recyclability, often the Achilles heel of homogeneous catalysts, proved to be a genuine strength here. After each run, PFPAT was recovered simply by extraction with ethyl acetate, dried under vacuum and reused without any further treatment. The catalyst retained its activity effectively through four consecutive cycles, with only a slight loss attributable to partial solubility in the aqueous phase. On the fifth cycle, performance dropped more sharply, with product yield falling to 70 percent and catalyst recovery to 63 percent, but the overall pattern still marks PFPAT as a viable, eco-friendly option for repeated use. Combined with yields of 72 to 94 percent across the substrate range, short reaction times, operational simplicity and the complete elimination of reaction solvents, the protocol offers a template for sustainable heterocyclic synthesis. The authors suggest that future work could expand the substrate scope, probe the biological activities of the products, and evaluate whether the process can be scaled for industrial application, a prospect that would bring a 140-year-old reaction firmly into the era of green chemistry.</p>
<p><strong>Subject of Research:</strong> Green solvent-free Brønsted acid-catalyzed synthesis of polyhydroquinoline derivatives via Hantzsch multicomponent reaction</p>
<p><strong>Article Title:</strong> An optimized and sustainable Brønsted acid-catalyzed green synthesis of polyhydroquinoline derivatives</p>
<p><strong>Article References:</strong> Pande, P., Niralwad, K., &amp; Patki, A. (2026). An optimized and sustainable Brønsted acid-catalyzed green synthesis of polyhydroquinoline derivatives. <em>Discover Chemistry, 3</em>(1), Article 551. <a href="https://doi.org/10.1007/s44371-026-00996-9" rel="noopener noreferrer">https://doi.org/10.1007/s44371-026-00996-9</a></p>
<p><strong>Image Credits:</strong> AI Generated</p>
<p><strong>DOI:</strong> <a href="https://doi.org/10.1007/s44371-026-00996-9" rel="noopener noreferrer">10.1007/s44371-026-00996-9</a></p>
<p><strong>Keywords:</strong> polyhydroquinolines, PFPAT, green chemistry, Hantzsch reaction, Brønsted acid catalysis, multicomponent reactions, solvent-free synthesis, catalyst recyclability, heterocyclic chemistry, drug discovery, Knoevenagel condensation, sustainable synthesis</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">221794</post-id>	</item>
	</channel>
</rss>
